Abstract: A non-limiting example training instrument comprises a hollow main body formed of an aluminum alloy. The main body is constituted by two gripping portions opposite to each other with a space therebetween and a coupling portion coupling the two gripping portions. A load sensor is arranged in the coupling portion inside the main body. The load sensor is a load cell, a strain gauge affixed to an interior of the main body, and a part of the main body to which the strain gauge is affixed functions as a strain body. Therefore, if a user applies a force so as to bring the two gripping portions close to each other or a force so as to move the two gripping portions away from each other, a load thereof is detected by the load sensor.

Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.

Abstract: Provided is a magnesium secondary battery including a positive electrode member 23 including at least a positive electrode active material layer 23B, a separator 24 disposed facing the positive electrode member 23, a negative electrode member 25 containing magnesium or a magnesium compound disposed facing the separator 24, and an electrolytic solution containing a magnesium salt. The positive electrode active material layer 23B includes magnesium sulfide having a zinc blende type crystal structure.

Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.

Abstract: A non-limiting example training instrument comprises a hollow main body formed of an aluminum alloy. The main body is constituted by two gripping portions opposite to each other with a space therebetween and a coupling portion coupling the two gripping portions. A load sensor is arranged in the coupling portion inside the main body. The load sensor is a load cell, a strain gauge affixed to an interior of the main body, and a part of the main body to which the strain gauge is affixed functions as a strain body. Therefore, if a user applies a force so as to bring the two gripping portions close to each other or a force so as to move the two gripping portions away from each other, a load thereof is detected by the load sensor.

Abstract: An example of a display system includes a sensor, a projector, and control means. The sensor senses user information for calculating a state regarding sleep of a user. The user information is, for example, biological information such as pulse. The projector projects and displays a predetermined image. The projector, for example, projects the image upward to project and display the image on the ceiling. The control means controls the projector in accordance with a state regarding sleep, which is calculated on the basis of the user information.

Abstract: An example of a display system includes a sensor, a projector, and control means. The sensor senses user information for calculating a state regarding sleep of a user. The user information is, for example, biological information such as pulse. The projector projects and displays a predetermined image. The projector, for example, projects the image upward to project and display the image on the ceiling. The control means controls the projector in accordance with a state regarding sleep, which is calculated on the basis of the user information.

Abstract: A non-limiting example training instrument comprises a hollow main body formed of an aluminum alloy. The main body is constituted by two gripping portions opposite to each other with a space therebetween and a coupling portion coupling the two gripping portions. A load sensor is arranged in the coupling portion inside the main body. The load sensor is a load cell, a strain gauge affixed to an interior of the main body, and a part of the main body to which the strain gauge is affixed functions as a strain body. Therefore, if a user applies a force so as to bring the two gripping portions close to each other or a force so as to move the two gripping portions away from each other, a load thereof is detected by the load sensor.

Abstract: Provided is a projection system that sets an arbitrary three-dimensional shape as a projection target and properly corrects geometric distortion of a projected image even when a user's viewpoint is not fixed. A projection unit of the projector apparatus projects a test image for first adjustment. A three-dimensional shape measurement unit measures the three-dimensional shape of the projection target. An image capturing apparatus captures the test image for first adjustment projected by the projection unit to obtain a captured image for first adjustment.

Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.

Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.

Abstract: Provided is a projection system that easily and appropriately reduces the geometric distortion of the image projected on the projection plane. The projection circuitry 3 of the projection system 1000 projects a test image onto the projection plane. The three-dimensional shape measurement circuitry 4 measures the three-dimensional shape of the projection plane. The controller 200 generates a control signal. Based on the measured three-dimensional shape data, the projection image adjustment circuitry 1 performs correction processing and rotation processing on a test, in accordance with the control signal, such that the geometrical image distortion is reduced as viewed from the user's viewpoint.

Abstract: Provided is a projection system that easily and appropriately reduces the geometric distortion of the image projected on the projection plane. The projection circuitry 3 of the projection system 1000 projects a test image onto the projection plane. The three-dimensional shape measurement circuitry 4 measures the three-dimensional shape of the projection plane. The controller 200 generates a control signal. Based on the measured three-dimensional shape data, the projection image adjustment circuitry 1 performs correction processing and rotation processing on a test, in accordance with the control signal, such that the geometrical image distortion is reduced as viewed from the user's viewpoint.

Abstract: Provided is a projection system that sets an arbitrary three-dimensional shape as a projection target and properly corrects geometric distortion of a projected image even when a user's viewpoint is not fixed. A projection unit of the projector apparatus projects a test image for first adjustment. A three-dimensional shape measurement unit measures the three-dimensional shape of the projection target. An image capturing apparatus captures the test image for first adjustment projected by the projection unit to obtain a captured image for first adjustment.

Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.

Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.

Abstract: An example of a display system includes a sensor, a projector, and control means. The sensor senses user information for calculating a state regarding sleep of a user. The user information is, for example, biological information such as pulse. The projector projects and displays a predetermined image. The projector, for example, projects the image upward to project and display the image on the ceiling. The control means controls the projector in accordance with a state regarding sleep, which is calculated on the basis of the user information.

Abstract: An information processing apparatus is set to always obtain information, even while an application is not being executed, and effectively using the obtained information. A state of the environment in a place where the information processing apparatus is present is detected. Detection data indicating the state of the environment detected by the detection section is stored. An operation mode is switched at least between a normal mode in which power is being supplied to the application execution section and the predetermined application can be executed, and a power saving mode in which at least supply of power to the application execution section is restricted and the predetermined application cannot be executed. At least in the power saving mode, a state of the environment is detected, and detection data indicating the state of the environment detected is stored in the first storage section at predetermined time intervals.

Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.

Abstract: An operating device has a narrow housing, and in this housing, an acceleration sensor and/or a gyro sensor are accommodated. Operation data inclusive of acceleration data and/or angular velocity data acquired from the acceleration sensor and/or the gyro sensor is transmitted by an operation data transmitter. Then, at a lower end of the housing, an elastic member having a spherical surface or substantially a spherical surface is provided.